Literature DB >> 989113

Mortality in patients treated for pulmonary embolism.

J S Alpert, R Smith, J Carlson, I S Ockene, L Dexter, J E Dalen.   

Abstract

The hospital course of 144 consecutive patients with pulmonary embolism (PE) demonstrated by pulmonary angiography was reviewed to determine the mortality of patients with treated PE. Twelve patients (8%) died of PE, and eight died of causes other than PE; 124 (86%) survived. Pulmonary embolism was the primary cause of death in only four of the 12 patients who died of PE. Pulmonary embolism contributed to the death of eight other patients, each of whom had associated potentially lethal disease, particularly heart disease. The most important factor affecting mortality was shock due to acute right ventricular failure secondary to massive PE (mortality, 32%). Mortality was not related to magnitude of PE per se; the mortality of patients with massive PE without shock (6%) was the same as that for patients with submassive PE (5%. Patients with PE who survive long enough to have the diagnosis established and appropriate prophylactic therapy begun have an excellent prognosis, unless they have associated severe medical disease.

Entities:  

Mesh:

Year:  1976        PMID: 989113

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  34 in total

Review 1.  The adult respiratory distress syndrome. New insights into diagnosis, pathophysiology, and treatment.

Authors:  M A Matthay
Journal:  West J Med       Date:  1989-02

Review 2.  When should we thrombolyse patients with pulmonary embolism? A systematic review of the literature.

Authors:  T Harris; S Meek
Journal:  Emerg Med J       Date:  2005-11       Impact factor: 2.740

3.  D-dimer for the diagnosis of acute venous thromboembolism in the emergency department: a Janus-face marker.

Authors:  Roberto Manfredini
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

4.  Outpatient diagnosis of pulmonary embolism: the MIOPED (Manchester Investigation Of Pulmonary Embolism Diagnosis) study.

Authors:  K Hogg; D Dawson; K Mackway-Jones
Journal:  Emerg Med J       Date:  2006-02       Impact factor: 2.740

5.  Pulmonary scintigraphy at the bedside in intensive care patients with suspected pulmonary embolism.

Authors:  P Jolliet; D O Slosman; B Ricou; P M Suter; J C Chevrolet
Journal:  Intensive Care Med       Date:  1995-09       Impact factor: 17.440

6.  The autopsy and diagnosis of pulmonary thrombo-embolism.

Authors:  Milton J Micallef
Journal:  Forensic Sci Med Pathol       Date:  2018-02-05       Impact factor: 2.007

7.  Fibrinogen beta-chain tyrosine nitration is a prothrombotic risk factor.

Authors:  Ioannis Parastatidis; Leonor Thomson; Anne Burke; Irina Chernysh; Chandrasekaran Nagaswami; Jetze Visser; Sheryl Stamer; Daniel C Liebler; George Koliakos; Harry F G Heijnen; Garret A Fitzgerald; John W Weisel; Harry Ischiropoulos
Journal:  J Biol Chem       Date:  2008-09-25       Impact factor: 5.157

8.  Early anticoagulation is associated with reduced mortality for acute pulmonary embolism.

Authors:  Sean B Smith; Jeffrey B Geske; Jennifer M Maguire; Nicholas A Zane; Rickey E Carter; Timothy I Morgenthaler
Journal:  Chest       Date:  2010-01-15       Impact factor: 9.410

9.  The autopsy incidence of acute pulmonary embolism in critically ill surgical patients.

Authors:  D J Cullen; A R Nemeskal
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

10.  Choice of marker for assessment of RV dysfunction in acute pulmonary embolism : NT-proBNP, pulmonary artery systolic pressure, mean arterial pressure, or blood pressure index.

Authors:  H Ates; I Ates; H Kundi; F M Yilmaz
Journal:  Herz       Date:  2016-12-13       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.